1. 2219: Amyotrophic lateral sclerosis, stem cells and TALENted technology. Issue 1 (10th May 2018) Authors: Kurani, Shaheen; Madigan, Nicolas; Clark, Karl; Ekker, Stephen; Staff, Nathan; Windebank, Anthony Journal: Journal of clinical and translational science Issue: Volume 1:Issue 1(2017) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 320 Genetic Compensation as a mechanism underlying patients with Rare ALS. (April 2022) Authors: Gomez, Adriana Morales; Staff, Nathan; Ekker, Stephen C. Journal: Journal of clinical and translational science Issue: Volume 6(2022)Supplement 1 Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neuronal Protection for Chemotherapy Neuropathy Prevention?. (15th May 2019) Authors: Loprinzi, Charles L; Hershman, Dawn L; Staff, Nathan Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 1(2020) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial. Issue 10 (October 2021) Authors: Cudkowicz, Merit; Genge, Angela; Maragakis, Nicholas; Petri, Susanne; van den Berg, Leonard; Aho, Valtteri V; Sarapohja, Toni; Kuoppamäki, Mikko; Garratt, Chris; Al-Chalabi, Ammar; Kiernan, Matthew; Mathers, Susan; Henderson, Robert; Needham, Merrilee; Schultz, David; Löscher, Wolfgang; Mitrovic,... Journal: Lancet neurology Issue: Volume 20:Issue 10(2021) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗